Figure 1From: Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer riskComponents of the 25-gene panel. CGH, comparative genomic hybridization; emPCR, emulsion polymerase chain reaction; LIMS, laboratory information management system; LR, large rearrangement; MLPA, multiplex ligation-dependent probe amplification, NGS, next generation sequencing.Back to article page